The FDA has authorized the first clinical trial involving genetically engineered pig kidneys, signaling a move from isolated cases to structured patient testing. Developed by biotech company eGenesis, the organs have already demonstrated encouraging early outcomes in transplants at Massachusetts General Hospital.
Deutsch
English
Español
Français
Italiano
Nederlands
Polski
Português
Русский
Türkçe
Svenska
Chinese
Magyar